Zobrazeno 1 - 10
of 135
pro vyhledávání: '"P, Bombaron"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fabrice Barlesi, Adrien Dixmier, Didier Debieuvre, Christophe Raspaud, Jean-Bernard Auliac, Nicolas Benoit, Pierre Bombaron, Denis Moro-Sibilot, Clarisse Audigier-Valette, Bernard Asselain, Thomas Egenod, Audrey Rabeau, Jérôme Fayette, Myriam Locatelli Sanchez, Jean-Luc Labourey, Virginie Westeel, Pauline Lamoureux, François-Emery Cotte, Victoria Allan, Melinda Daumont, Juliette Dumanoir, Dorothée Reynaud, Christophe Yannick Calvet, Nicolas Ozan, Maurice Pérol
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
EVIDENS is an ongoing, prospective, non-interventional study evaluating the effectiveness and safety of nivolumab in lung cancer patients in France (ClinicalTrials.gov NCT03382496). Adults with a pathologically confirmed diagnosis of lung cancer and
Externí odkaz:
https://doaj.org/article/213acd05a7a34a719db64a6b6903acd4
Autor:
D Waldenberger, John R. Penrod, Clarisse Audigier-Valette, Sylvia Gütz, Martin Sebastian, Adrien Dixmier, Christian Schumann, Khalid Lakhdari, Rosalyn A. Juergens, Didier Debieuvre, P. Bombaron, Nicolas Benoit, Jean-Bernard Auliac, Ariadna Juarez-Garcia, Catherine Labbé, Victoria Allan, Christophe Raspaud, Bernard Asselain, Dorothee Reynaud, Andreas Gröschel, Fabrice Barlesi, Maurice Pérol, Filippa Pettersson, Charles A. Butts, Denis Moro-Sibilot
Publikováno v:
Lung Cancer. 157:40-47
Objectives Immune checkpoint inhibitors have become the standard of care for metastatic non–small-cell lung cancer (NSCLC) progressing during or after platinum-based chemotherapy. Real-world clinical practice tends to represent more diverse patient
Autor:
Chour, Ali, Denis, Julie, Mascaux, Céline, Zysman, Maeva, Bigay-Game, Laurence, Swalduz, Aurélie, Gounant, Valérie, Cortot, Alexis, Darrason, Marie, Fallet, Vincent, Auclin, Edouard, Basse, Clémence, Tissot, Claire, Decroisette, Chantal, Bombaron, Pierre, Giroux-Leprieur, Etienne, Odier, Luc, Brosseau, Solenn, Creusot, Quentin, Gueçamburu, Marina, Meersseman, Corentin, Rochand, Adrien, Costantini, Adrien, Gaillard, Claire Marine, Wasielewski, Eric, Girard, Nicolas, Cadranel, Jacques, Lafitte, Claire, Lebossé, Fanny, Duruisseaux, Michaël
Publikováno v:
Journal of Thoracic Oncology; October 2023, Vol. 18 Issue: 10 p1408-1415, 8p
Autor:
D. Moro Sibilot, F. Barlesi, A. Dixmier, C. Raspaud, J.B. Auliac, P. Bombaron, D. Debieuvre, B. Asselain, E. Gauthier, C. Audigier-Valette, D. Reynaud, M. Pérol
Publikováno v:
Revue des Maladies Respiratoires Actualités. 15:130
Autor:
A. Chour, J. Denis, C. Lafitte, C. Mascaux, M. Zysman, A. Lemaitre, A. Swalduz, V. Gounant, A. Cortot, M. Darrason, J. Cadranel, E. Auclin, C. Basse, C. Tissot, C. Decroisette, P. Bombaron, E. Giroux-Leprieur, L. Falchero, F. Lebossé, M. Duruisseaux
Publikováno v:
Annals of Oncology. 33:S49-S50
Autor:
D. Debieuvre, F. Barlesi, A. Dixmier, C. Raspaud, J.B. Auliac, B. Nicolas, P. Bombaron, D. Moro-Sibilot, B. Asselain, F.E. Cotte, N. Goyard, E. Gauthier, D. Reynaud, C. Audigier-Valette, M. Pérol
Publikováno v:
Revue des Maladies Respiratoires Actualités. 14:198-199
Autor:
Hélène Labrosse, Pierre-Paul Bringuier, Muriel Rogasik, Philippe Brun, Pierre-Jean Souquet, P. Bombaron, Camille Schiffler, Véronique Haddad, Sylvie Lantuejoul, Fadila Farsi, Chantal Decroisette, Pierre Fournel, Florence de Fraipont, Denis Moro-Sibilot, Isabelle Ray-Coquard, Fabien Forest, Yohan Fayet, Maurice Pérol, Sylvie Chabaud, Aurélie Swalduz, Michel Peoc'h
Publikováno v:
Future Oncology. 15:2139-2149
Aim: We performed a clinical audit of the management of patients with EGFR mutations, 1 year after the introduction of EGFR tyrosine kinase inhibitor ( EGFR-TKI) in first-line treatment. Methods: Compliance was defined by tumor molecular profiling fo
Autor:
Pauline Lamoureux, Denis Moro-Sibilot, Thomas Egenod, P. Bombaron, Melinda Daumont, Audrey Rabeau, Adrien Dixmier, Christophe Raspaud, Nicolas Benoit, Didier Debieuvre, N. Ozan, Juliette Dumanoir, Bernard Asselain, Virginie Westeel, C. Calvet, Clarisse Audigier-Valette, Dorothee Reynaud, Victoria Allan, Fabrice Barlesi, François-Emery Cotté, Maurice Pérol, Jean-Bernard Auliac, Jérôme Fayette, Jean-Luc Labourey, Myriam Locatelli Sanchez
Publikováno v:
Oncoimmunology
article-version (VoR) Version of Record
OncoImmunology, Vol 9, Iss 1 (2020)
article-version (VoR) Version of Record
OncoImmunology, Vol 9, Iss 1 (2020)
EVIDENS is an ongoing, prospective, non-interventional study evaluating the effectiveness and safety of nivolumab in lung cancer patients in France (ClinicalTrials.gov NCT03382496). Adults with a pathologically confirmed diagnosis of lung cancer and
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.